Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study
Kurzrock, R., Bowles, D.W., Kang, H., Meric-Bernstam, F., Hainsworth, J., Spigel, D.R., Bose, R., Burris, H., Sweeney, C.J., Beattie, M.S., Blotner, S., Schulze, K., Cuchelkar, V., Swanton, C.
Published in Annals of oncology (01.03.2020)
Published in Annals of oncology (01.03.2020)
Get full text
Journal Article
Influence of chronic hepatitis C infection on cytochrome P450 3a4 activity using midazolam as an in vivo probe substrate
Morcos, P. N., Moreira, S. A., Brennan, B. J., Blotner, S., Shulman, N. S., Smith, P. F.
Published in European journal of clinical pharmacology (01.10.2013)
Published in European journal of clinical pharmacology (01.10.2013)
Get full text
Journal Article
Safety, Tolerability, and Pharmacokinetics of Ribavirin in Hepatitis C Virus-Infected Patients with Various Degrees of Renal Impairment
BRENNAN, B. J, WANG, K, BLOTNER, S, MAGNUSSON, M. O, WILKINS, J. J, MARTIN, P, SOLSKY, J, NIEFORTH, K, WAT, C, GRIPPO, J. F
Published in Antimicrobial Agents and Chemotherapy (01.12.2013)
Published in Antimicrobial Agents and Chemotherapy (01.12.2013)
Get full text
Journal Article
A phase I study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, for intravenous (IV) administration in patients with advanced solid tumors
Razak, A, Gore, L, Britten, C.D, Miller, W.H, Uy, G.L, Nichols, G, Middleton, S, Blotner, S, Zhi, J, Jukofsky, L, Pierceall, W, Higgins, B, Chen, L.C
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
The pharmacokinetics of peginterferon alfa-2a and ribavirin in African American, Hispanic and Caucasian patients with chronic hepatitis C
Brennan, B. J., Morcos, P. N., Wang, K., Blotner, S. D., Morrison, R., Hagedorn, C. H., Marbury, T. C., Sulkowski, M., Grippo, J. F.
Published in Alimentary pharmacology & therapeutics (01.05.2012)
Published in Alimentary pharmacology & therapeutics (01.05.2012)
Get full text
Journal Article
753 IMPACT OF LOW DOSE RITONAVIR BOOSTING ON THE PHARMACOKINETICS OF RG7227 (ITMN-191), A HIGHLY POTENT AND SELECTIVE INHIBITOR OF THE HCV NS3/4A PROTEASE
Haznedar, J.Ö, Fretland, J, Leong, G, Blotner, S, Hill, T, Smith, P, Tran, J.Q
Published in Journal of hepatology (2010)
Published in Journal of hepatology (2010)
Get full text
Journal Article
Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis
Kremer, J M, Furst, D E, Weinblatt, M E, Blotner, S D
Published in Journal of rheumatology (01.03.1996)
Get more information
Published in Journal of rheumatology (01.03.1996)
Journal Article
Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts
Reis, Bernhard, Jukofsky, Lori, Chen, Gong, Martinelli, Giovanni, Zhong, Hua, So, W Venus, Dickinson, Michael J, Drummond, Mark, Assouline, Sarit, Hashemyan, Maneja, Theron, Michel, Blotner, Steven, Lee, Je-Hwan, Kasner, Margaret, Yoon, Sung-Soo, Rueger, Ruediger, Seiter, Karen, Middleton, Steven A, Kelly, Kevin R, Vey, Norbert, Yee, Karen, Nichols, Gwen, Chen, Lin-Chi, Pierceall, William E
Published in Haematologica (Roma) (01.05.2016)
Published in Haematologica (Roma) (01.05.2016)
Get full text
Journal Article
45 - A phase I study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, for intravenous (IV) administration in patients with advanced solid tumors
Razak, A., Gore, L., Britten, C.D., Miller, W.H., Uy, G.L., Nichols, G., Middleton, S., Blotner, S., Zhi, J., Jukofsky, L., Pierceall, W., Higgins, B., Chen, L.C.
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Effect of Food and Esomeprazole on the Pharmacokinetics of Alectinib, a Highly Selective ALK Inhibitor, in Healthy Subjects
Morcos, Peter N., Guerini, Elena, Parrott, Neil, Dall, Georgina, Blotner, Steven, Bogman, Katrijn, Sturm, Carolina, Balas, Bogdana, Martin‐Facklam, Meret, Phipps, Alex
Published in Clinical pharmacology in drug development (01.07.2017)
Published in Clinical pharmacology in drug development (01.07.2017)
Get full text
Journal Article
The pharmacokinetics of peginterferon alfa‐2a and ribavirin in A frican A merican, H ispanic and C aucasian patients with chronic hepatitis C
Brennan, B. J., Morcos, P. N., Wang, K., Blotner, S. D., Morrison, R., Hagedorn, C. H., Marbury, T. C., Sulkowski, M., Grippo, J. F.
Published in Alimentary pharmacology & therapeutics (01.05.2012)
Published in Alimentary pharmacology & therapeutics (01.05.2012)
Get full text
Journal Article
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C
Prati, Daniele, Shiffman, Mitchell L., Diago, Moisés, Gane, Edward, Rajender Reddy, K., Pockros, Paul, Farci, Patrizia, O'Brien, Christopher B., Lardelli, Pilar, Blotner, Steven, Zeuzem, Stefan
Published in Journal of hepatology (01.04.2006)
Published in Journal of hepatology (01.04.2006)
Get full text
Journal Article
First-in-human, safety, pharmacodynamic (PD) and pharmacokinetic (PK) trial of a first-in-class dual RAF/MEK inhibitor, RO5126766, in patients with advanced or metastatic solid tumors
Dolly, S. O., Albanell, J., Kraeber-Bodere, F., Banerji, U., Bahleda, R., Martinez Garcia, M., Xu, Z. X., Guarin, E., Tessier, J., Shochat, E., Deutsch, J., Blotner, S., Meresse, V., Soria, J.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Phase I (Ph) safety, pharmacodynamic (PD), and pharmacokinetic (PK) trial of a pure MEK inhibitor (i), RO4987655, in patients with advanced /metastatic solid tumor
Leijen, S., Middleton, M. R., Tresca, P., Kraeber-Bodere, F., Dieras, V., Scheulen, M. E., Tessier, J., Xu, Z. X., Shochat, E., Walz, A., Deutsch, J., Blotner, S., Lopez Valverde, V., Naegelen, V. M., Schellens, J. H. M., Eberhardt, W. E.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin
Weinblatt, M E, Polisson, R, Blotner, S D, Sosman, J L, Aliabadi, P, Baker, N, Weissman, B N
Published in Arthritis and rheumatism (01.05.1993)
Published in Arthritis and rheumatism (01.05.1993)
Get more information
Journal Article
Short-Term Orlistat Treatment Does Not Affect Mineral Balance and Bone Turnover in Obese Men
Pace, Daniel G., Blotner, Steven, Guerciolini, Roberto
Published in The Journal of nutrition (01.06.2001)
Published in The Journal of nutrition (01.06.2001)
Get full text
Journal Article
Project transition: competitive employment service for the severely handicapped mentally retarded
Revell, Jr, W G, Arnold, S, Taylor, B, Zaitz-Blotner, S
Published in The Journal of rehabilitation (01.01.1982)
Get full text
Published in The Journal of rehabilitation (01.01.1982)
Journal Article
Methods for personalizing patient cancer therapy with an mdm2 antagonist
BLOTNER STEVEN D, NICHOLS GWEN, PIERCEALL WILLIAM E, RUEGER RUEDIGER, CHEN GONG, ZHONG HUA, REIS BERNHARD, JUKOFSKY LORI
Year of Publication 24.05.2017
Get full text
Year of Publication 24.05.2017
Patent